NDC 13668-202 – Darifenacin

Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug 2 recalls

Product NDC13668-202

Product details

Brand name
Darifenacin
Generic name
Darifenacin
Labeler
Torrent Pharmaceuticals Limited
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA205209
Marketed since
November 18, 2016
Listing expires
December 31, 2027
Pharmacologic class
Cholinergic Muscarinic Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Darifenacin →

Package NDC codes (3)

Package NDCDescriptionSince
13668-202-05500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-05)Nov 18, 2016
13668-202-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-30)Nov 18, 2016
13668-202-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-90)Nov 18, 2016

Recalls mentioning this NDC

Other Darifenacin products